{
    "SPADE_UN_11847": {
        "Clinical Information": [],
        "Patent Information": [],
        "Sequence Information": {
            "SPADE ID": "SPADE_UN_11847",
            "Peptide Name": "Feleucin-K3 (Derived from Feleucin-BO1)",
            "Source": "Synthetic construct",
            "Family": "Not found",
            "Gene": "Not found",
            "Sequence": "FLKLLKKLL",
            "Sequence Length": 9,
            "UniProt Entry": "No entry found",
            "Protein Existence": "Synthetic form",
            "Biological Activity": [
                "Antimicrobial",
                "Antibacterial",
                "Anti-Gram+",
                "Anti-Gram-",
                "Antifungal"
            ],
            "Target Organism": "[Ref.25056849] Gram-positive bacteria :Staphylococcus aureus(MIC=34 μM, MBC=128 μM)",
            "Hemolytic Activity": "[Ref.25056849] 100% hemolysis at >250 mg/L against horse red blood cells",
            "Cytotoxicity": "No cytotoxicity information found in the reference(s) presented",
            "Binding Target": "Not found",
            "Linear/Cyclic": "Linear",
            "N-terminal Modification": "Free",
            "C-terminal Modification": "Amidation",
            "Stereochemistry": "L",
            "Structure Description": "In F-K3, these latter residues are substituted with Lys (K) residues, whose side-chains occupied the same positions, producing a model cationic amphipathic character in this analogue.",
            "Formula": "C57H102N12O10",
            "Mass": 1115.49,
            "PI": 10.3,
            "Net Charge": 3,
            "Hydrophobicity": 1.12,
            "Half Life": "Mammalian:1.1 hourYeast:3 minE.coli:2 min",
            "Function": "Antibacterial activity against Gram-positive bacteria",
            "Literature": [
                {
                    "Title": "Feleucin-BO1 A Novel Antimicrobial Non-Apeptide Amide from the Skin Secretion of the Toad, Bombina orientalis, and Design of a Potent Broad-Spectrum Synthetic Analogue, Feleucin-K3",
                    "Pubmed ID": "25056849",
                    "Reference": "Chem Biol Drug Des. 2015 Mar;85(3)259-67. doi 10.1111/cbdd.12396.",
                    "Author": "Xiaojuan Hou, Qiang Du, Renjie Li, Mei Zhou, Hui Wang2, Lei Wang2, Can Guo, Tianbao Chen and Chris Shaw",
                    "URL": "http://www.ncbi.nlm.nih.gov/pubmed/?term=25056849"
                },
                {
                    "Title": "Feleucin-BO1: A novel Antimicrobial non-Apeptide Amide from the Skin Secretion of the Toad, Bombina orientalis, and Design of a Potent Broad-Spectrum Synthetic Analogue, Feleucin-K3",
                    "Pubmed ID": "",
                    "Author": "Hou X, Du Q, Li R, Zhou M, Wang H, Wang L, Guo C, Chen T, Shaw C"
                },
                {
                    "Title": "Potent effects of amino acid scanned antimicrobial peptide Feleucin-K3 analogs against both multidrug-resistant strains and biofilms of Pseudomonas aeruginosa",
                    "Pubmed ID": "",
                    "Author": "Xie J, Li Y, Li J, Yan Z, Wang D, Guo X, Zhang J, Zhang B, Mou L, Yang W, Jiang X"
                }
            ],
            "Frequent Amino Acids": "LKF",
            "Absent Amino Acids": "ACDEGHIMNOPQRSTUVWY",
            "Basic Residues": 3,
            "Acidic Residues": 0,
            "Hydrophobic Residues": 6,
            "Polar Residues": 3,
            "Positive Residues": 3,
            "Negative Residues": 0,
            "Similar Sequences": [
                {
                    "SPADE_ID": "SPADE_N_06813",
                    "Similarity": 1.0,
                    "Sequence": "DGRELCLDPKENWVQRVVEKFLK"
                },
                {
                    "SPADE_ID": "SPADE_N_10600",
                    "Similarity": 1.0,
                    "Sequence": "KAGLQFPVGRIARFLK"
                },
                {
                    "SPADE_ID": "SPADE_N_12648",
                    "Similarity": 1.0,
                    "Sequence": "KKFFRAWWAPRFLK"
                }
            ]
        }
    }
}